David Shaw
DMIIR icon

David Shaw’s Drugs Made In America Acquisition II Corp Right DMIIR Stock Holding History

David Shaw’s Portfolio DMIIR Stock Details DMIIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$72.7K Hold
1,000,000
– – ﹤0.01% 4676
2026
Q1 		$80K Hold
1,000,000
– – ﹤0.01% 4306
2025
Q4 		$140K Buy
+1,000,000
New +$143K ﹤0.01% 4375

Other funds holding DMIIR

Magnetar Financial
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Glazer Capital LLC
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Polar Asset Management Partners
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Tenor Capital Management
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
Aristeia Capital
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
HGC Investment Management
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return

David Shaw's DMIIR Position: Q2 2026 in Review

David Shaw held its Drugs Made In America Acquisition II Corp Right (DMIIR) position steady in Q2 2026 at 1,000,000 shares worth $72.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4676.

David Shaw first reported a position in DMIIR in Q4 2025 and has held it in 3 quarters since. The position peaked at $140K in Q4 2025. 62 funds tracked by Wall St. Rank hold DMIIR as of Q2 2026.

  • David Shaw held 1,000,000 shares of Drugs Made In America Acquisition II Corp Right worth $72.7K as of Q2 2026.
  • David Shaw left its Drugs Made In America Acquisition II Corp Right share count unchanged in Q2 2026.
  • Drugs Made In America Acquisition II Corp Right made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4676 holding.
  • David Shaw first reported a position in Drugs Made In America Acquisition II Corp Right in Q4 2025 and has held it in 3 quarters since.
  • David Shaw's Drugs Made In America Acquisition II Corp Right position peaked at $140K in Q4 2025.
  • 62 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Right as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.